Elite Pharmaceuticals, Inc.
ELTP
$0.40
-$0.021-4.99%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 42.59% | 10.41% | -7.38% | -9.27% | -67.52% |
Total Receivables | 15.27% | 104.32% | 230.35% | 528.64% | 188.68% |
Inventory | 40.72% | -6.96% | 23.84% | 35.39% | 66.53% |
Prepaid Expenses | 13.83% | -63.33% | -56.35% | -49.24% | -9.25% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 29.32% | 30.42% | 57.26% | 86.02% | 12.04% |
|
|||||
Total Current Assets | 29.32% | 30.42% | 57.26% | 86.02% | 12.04% |
Net Property, Plant & Equipment | 31.68% | 46.09% | 46.15% | 39.96% | 2.74% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | -37.94% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.85% | 9.29% | 242.10% | 231.97% | 202.37% |
Total Assets | 21.50% | 24.72% | 88.92% | 104.55% | 41.70% |
|
|||||
Total Accounts Payable | 102.04% | -45.05% | 39.05% | 10.93% | 96.35% |
Total Accrued Expenses | -73.81% | -52.66% | 3.07% | 3.97% | 157.15% |
Short-term Debt | 2.50% | 0.00% | 0.00% | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 202.78% | 288.43% | 348.71% | 213.20% | -24.87% |
Total Finance Division Other Current Liabilities | 3,770.68% | 3,156.39% | 23.19% | 16.44% | -80.41% |
Total Other Current Liabilities | 3,770.68% | 3,156.39% | 23.19% | 16.44% | -80.41% |
Total Current Liabilities | -23.33% | -32.63% | 16.04% | 66.59% | 187.91% |
|
|||||
Total Current Liabilities | -23.33% | -32.63% | 16.04% | 66.59% | 187.91% |
Long-Term Debt | -7.97% | -8.31% | -9.32% | -7.91% | -78.59% |
Short-term Debt | 2.50% | 0.00% | 0.00% | -- | -- |
Capital Leases | 1,395.52% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 498.72% | 584.14% | 1,150.08% | 1,066.04% | 1,308.57% |
Total Liabilities | 92.03% | 59.73% | 80.65% | 118.42% | 25.47% |
|
|||||
Common Stock & APIC | 4.82% | 5.16% | 5.16% | 5.14% | 0.41% |
Retained Earnings | -15.02% | -5.30% | 14.47% | 14.73% | 11.50% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -21.48% | 4.82% | 93.41% | 98.83% | 53.82% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -21.48% | 4.82% | 93.41% | 98.83% | 53.82% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -21.48% | 4.82% | 93.41% | 98.83% | 53.82% |
|